Literature DB >> 11981372

Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure.

Elena Delgado1, Michael M Thomson, María Luisa Villahermosa, María Sierra, Antonio Ocampo, Celia Miralles, Raúl Rodríguez-Pérez, Julio Diz-Aren, Rafael Ojea-de Castro, Elena Losada, María Teresa Cuevas, Elena Vázquez-de Parga, Rocío Carmona, Lucía Pérez-Alvarez, Leandro Medrano, Laureano Cuevas, José Antonio Taboada, Rafael Nájera.   

Abstract

We recently reported the finding of phylogenetically related HIV-1 BG intersubtype recombinant and G subtype nonrecombinant viruses circulating among injecting drug users in the region of Galicia in northwestern Spain. Here, we report the characterization of near full-length genome sequences of nine of these viruses (seven BG recombinant and two of nonrecombinant G subtype), obtained from epidemiologically unlinked individuals. Bootscan analysis reveals that six recombinant viruses share an identical mosaic structure, with two intersubtype breakpoints delimiting a B subtype segment comprising most of Env gp120 and the external portion of Env gp41, with the remaining portions of the genome being of subtype G, thus mimicking a pseudotype virion structure. The seventh BG recombinant virus exhibits breakpoints in env coincident with the other BG viruses but contains additional B subtype segments in gag and pol. In phylogenetic trees of complete genomes and of the B subtype segment of env, all seven BG viruses group in a monophyletic cluster. G subtype portions of the BG viruses group uniformly with the newly derived nonrecombinant G subtype viruses of Galicia in bootscan analysis, which points to the locally circulating G subtype strain as parental of the recombinants. These results allow us to define a new HIV-1 circulating recombinant form (CRF14_BG), the first reported to originate in Western Europe.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981372     DOI: 10.1097/00126334-200204150-00016

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Authors:  Gonzalo Yebra; Miguel de Mulder; Leticia Martín; Carmen Rodríguez; Pablo Labarga; Isabel Viciana; Juan Berenguer; María Remedios Alemán; Juan Antonio Pineda; Federico García; Africa Holguín
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Imbroglios of viral taxonomy: genetic exchange and failings of phenetic approaches.

Authors:  Jeffrey G Lawrence; Graham F Hatfull; Roger W Hendrix
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

3.  HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea.

Authors:  Cyrille F Djoko; Nathan D Wolfe; Nicole Vidal; Ubald Tamoufe; Celine Montavon; Matthew LeBreton; Brian L Pike; Joseph Fair; Wilfred F Mbacham; Alogos Benito; Anne W Rimoin; Karen Saylors; Eitel Mpoudi-Ngole; Michael P Grillo; Martine Peeters
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

Review 4.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Magdalena E Sobieszczyk; Francine E McCutchan; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

5.  Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.

Authors:  Yolanda Vega; Lucía Pérez-Alvárez; Elena Delgado; Mercedes Muñoz; Gema Casado; Rocío Carmona; María Sierra; Elena Vázquez de Parga; Milagros Pinilla; Valentina García; Leandro Medrano; Gerardo Contreras; Miguel Thomson; Rafael Nájera
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

7.  Genomic Diversity of Human Immunodeficiency Viruses.

Authors:  R M Gupta; A K Sahni; J Jena; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-05-30

8.  Short communication: Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia.

Authors:  Nadezhda S Shcherbakova; Lyudmila A Shalamova; Elena Delgado; Aurora Fernández-García; Yolanda Vega; Larissa I Karpenko; Alexander A Ilyichev; Yuri V Sokolov; Dmitry N Shcherbakov; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-14       Impact factor: 2.205

9.  Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.

Authors:  Rute Antunes; Sofia Figueiredo; Inês Bártolo; Manuel Pinheiro; Lino Rosado; Isabel Soares; Helena Lourenço; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.

Authors:  Rose Tsui; Belinda L Herring; Jason D Barbour; Robert M Grant; Peter Bacchetti; Alex Kral; Brian R Edlin; Eric L Delwart
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.